STOCK TITAN
  1. Home
  2. Sec-filings
  3. GLYC
  4. [Form 4] GlycoMimetics, Inc. Insider Trading Activity

[Form 4] GlycoMimetics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GLYC logo
Glycomimetics

NASDAQ:GLYC

GLYC Rankings

#6133 Ranked by Market Cap
N/A Ranked by Dividends

GLYC Latest News

Jun 5, 2025
GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals
Nov 12, 2024
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
Nov 6, 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Oct 29, 2024
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
Oct 29, 2024
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint

GLYC Latest SEC Filings

Aug 20, 2025
[SCHEDULE 13G] GlycoMimetics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] GlycoMimetics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] GlycoMimetics, Inc. SEC Filing
Jul 31, 2025
[8-K] GlycoMimetics, Inc. Reports Material Event
Jul 31, 2025
[10-Q] GlycoMimetics, Inc. Quarterly Earnings Report

GLYC Stock Data

11.00M
62.82M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
Link
US
ROCKVILLE